|
ES2601896T3
(es)
|
2004-11-24 |
2017-02-16 |
Fred Hutchinson Cancer Research Center |
Procedimientos de uso de la IL-21 en la inmunoterapia adoptiva y la identificación de antígenos tumorales
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
IL297773B2
(en)
|
2014-11-17 |
2024-07-01 |
Adicet Bio Inc |
Engineered gamma delta t-cells
|
|
JP6743051B2
(ja)
|
2015-01-27 |
2020-08-19 |
ラヴァ・セラピューティクス・ベー・フェー |
Ｃｄ１ｄを標的とする単一ドメイン抗体
|
|
GB201507368D0
(en)
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
ES2908840T3
(es)
|
2015-06-09 |
2022-05-04 |
Lymphact Lymphocyte Activation Tech S A |
Procedimiento para la producción de células T TCR gamma delta+
|
|
AU2016318163B2
(en)
|
2015-09-03 |
2022-07-14 |
Children's Healthcare Of Atlanta, Inc. |
Genetically-engineered drug resistant T cells and methods of using the same
|
|
CN118421557A
(zh)
*
|
2016-05-12 |
2024-08-02 |
阿迪塞特治疗公司 |
选择性扩增γδT细胞群的方法及其组合物
|
|
US10456423B2
(en)
|
2016-06-13 |
2019-10-29 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
US10426796B2
(en)
*
|
2016-06-13 |
2019-10-01 |
SMART SURGICAL, Inc. |
Compositions for biological systems and methods for preparing and using the same
|
|
JP7193862B2
(ja)
|
2016-08-03 |
2022-12-21 |
ワシントン・ユニバーシティ |
キメラ抗原受容体でのｔ細胞性悪性腫瘍の治療のためのｃａｒ－ｔ細胞の遺伝子編集
|
|
KR102032354B1
(ko)
|
2016-11-11 |
2019-10-16 |
가톨릭대학교 산학협력단 |
신규한 배양보조세포 및 이를 이용한 감마 델타 ｔ 세포의 증식 방법
|
|
CA3044593A1
(en)
|
2016-11-22 |
2018-05-31 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
US20210187022A1
(en)
*
|
2016-12-21 |
2021-06-24 |
TCR2 Therapeutics Inc. |
Engineered t cells for the treatment of cancer
|
|
US11629333B2
(en)
*
|
2017-02-08 |
2023-04-18 |
Agency For Science, Technology And Research |
Gamma delta T cells and a method of augmenting the tumoricidal activity of the same
|
|
CN118662615A
(zh)
|
2017-03-15 |
2024-09-20 |
浩康生物系统公司 |
用于造血干细胞移植的组合物和方法
|
|
GB201707048D0
(en)
|
2017-05-03 |
2017-06-14 |
King S College London |
Expansion of gamma delta cells, compositions, and methods of use thereof
|
|
US12384830B2
(en)
*
|
2017-06-02 |
2025-08-12 |
Regents Of The University Of Minnesota |
Compositions and methods for improving immunotherapy
|
|
WO2018236986A1
(en)
*
|
2017-06-20 |
2018-12-27 |
The Trustees Of Columbia University In The City Of New York |
Engineered t-cell receptors and methods of their use
|
|
EA202090149A1
(ru)
|
2017-06-28 |
2020-05-31 |
Ридженерон Фармасьютикалз, Инк. |
Антигенсвязывающие белки против вируса папилломы человека (hpv) и способы их применения
|
|
US20200297871A1
(en)
*
|
2017-09-15 |
2020-09-24 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
TWI687227B
(zh)
*
|
2017-10-03 |
2020-03-11 |
生倍科技股份有限公司 |
用於t細胞免疫療法之組合及其用途
|
|
CN109777778B
(zh)
*
|
2017-11-14 |
2023-07-18 |
中国科学院广州生物医药与健康研究院 |
一种基因改造的γδT细胞
|
|
SG11202004506WA
(en)
|
2017-11-15 |
2020-06-29 |
Adicet Bio Inc |
METHODS FOR SELECTIVE EXPANSION OF d3 ?d T-CELL POPULATIONS AND COMPOSITIONS THEREOF
|
|
DE102017127984B4
(de)
|
2017-11-27 |
2019-12-05 |
Immatics US, Inc. |
Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
|
|
CN108129566B
(zh)
*
|
2017-12-31 |
2021-05-11 |
中国科学院武汉病毒研究所 |
靶向间皮素的c-型单域抗体及其制备方法与应用
|
|
EP3765054A4
(en)
*
|
2018-01-19 |
2022-01-12 |
The Trustees Of The University Of Pennsylvania |
COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T LYMPHOCYTES USING CHIMERIC ANTIGEN RECEPTORS
|
|
US12077598B2
(en)
|
2018-03-16 |
2024-09-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Chimeric antigen receptors with mutated CD28 phosphorylation sites
|
|
GB201804701D0
(en)
|
2018-03-23 |
2018-05-09 |
Gammadelta Therapeutics Ltd |
Lymphocytes expressing heterologous targeting constructs
|
|
JP7055469B2
(ja)
*
|
2018-05-08 |
2022-04-18 |
国立大学法人大阪大学 |
ホモ接合型細胞の作製方法
|
|
CN110577932A
(zh)
*
|
2018-06-07 |
2019-12-17 |
亘喜生物科技（上海）有限公司 |
一种脐带血来源的嵌合抗原受体t细胞
|
|
EP3823993A1
(en)
*
|
2018-07-18 |
2021-05-26 |
Amgen Inc. |
Chimeric receptors to steap1 and methods of use thereof
|
|
CN118459590A
(zh)
|
2018-08-01 |
2024-08-09 |
感应检查疗法公司 |
抗btn3a抗体及其在治疗癌症或感染性病症中的用途
|
|
CN108949685B
(zh)
*
|
2018-08-02 |
2022-03-29 |
吉林大学第一医院 |
一种体外诱导扩增高杀伤活性γδT细胞的方法
|
|
US20210177903A1
(en)
*
|
2018-08-07 |
2021-06-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Car t-cells for the treatment of bone metastatic cancer
|
|
US12156888B2
(en)
|
2018-08-07 |
2024-12-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CAR T-cells for the treatment of bone metastatic cancer
|
|
WO2020029171A1
(zh)
*
|
2018-08-09 |
2020-02-13 |
深圳华大生命科学研究院 |
无内源hla基因背景的抗原递呈细胞系的构建方法、抗原递呈细胞系及其用途
|
|
CN119709615A
(zh)
*
|
2018-08-10 |
2025-03-28 |
国立大学法人京都大学 |
Cd3阳性细胞的制造方法
|
|
CN113307872B
(zh)
*
|
2018-08-11 |
2022-12-06 |
广东天科雅生物医药科技有限公司 |
一种工程化核酸、t细胞及其应用和产生方法
|
|
CN109161533B
(zh)
*
|
2018-08-28 |
2020-07-24 |
深圳市菲鹏生物制药股份有限公司 |
无血清培养组合物及其应用
|
|
MX2021003234A
(es)
|
2018-09-19 |
2021-07-16 |
Lava Therapeutics N V |
Inmunoglobulina de la molecula cd1d de acción dual.
|
|
US20210388100A1
(en)
*
|
2018-10-01 |
2021-12-16 |
Adicet Bio, Inc. |
Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of hematological tumors
|
|
BR112021006254A2
(pt)
*
|
2018-10-01 |
2021-07-27 |
Adicet Bio, Inc. |
composições e métodos relativos a células t¿d engenheiradas e não engenheiradas para tratamento de tumores sólidos
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
EA202191107A1
(ru)
|
2018-10-23 |
2021-09-17 |
Ридженерон Фармасьютикалз, Инк. |
T-клеточные рецепторы ny-eso-1 и способы их применения
|
|
GB201818243D0
(en)
|
2018-11-08 |
2018-12-26 |
Gammadelta Therapeutics Ltd |
Methods for isolating and expanding cells
|
|
KR20210099615A
(ko)
|
2018-12-03 |
2021-08-12 |
아디셋 바이오, 인크. |
감마 델타 t-세포 집단의 선택적 생체내 확장을 위한 방법 및 이의 조성물
|
|
CN111544585B
(zh)
*
|
2019-02-11 |
2024-12-27 |
北京卡替医疗技术有限公司 |
一种可助推免疫细胞在体内扩增的佐剂
|
|
JP6884450B2
(ja)
*
|
2019-02-14 |
2021-06-09 |
学校法人獨協学園獨協医科大学 |
Ｔ細胞ワクチン
|
|
EP3927735A4
(en)
*
|
2019-02-18 |
2023-09-06 |
Memorial Sloan Kettering Cancer Center |
COMBINATIONS OF MULTIPLE CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY
|
|
US20220143086A1
(en)
*
|
2019-02-24 |
2022-05-12 |
Gamida Cell Ltd. |
Method of homing and retention of gammadelta t cells, optionally with natural killer cells, for generating cell compositions for use in therapy
|
|
EP3935151A1
(en)
*
|
2019-03-08 |
2022-01-12 |
Klinikum der Universität München |
Ccr8 expressing lymphocytes for targeted tumor therapy
|
|
CN109758590B
(zh)
*
|
2019-03-28 |
2022-02-11 |
广东工业大学 |
一种用于筛选人前列腺癌肿瘤抗原表位肽的方法
|
|
MX2021012004A
(es)
*
|
2019-03-30 |
2021-11-04 |
Biontech Us Inc |
Composiciones y metodos para preparar composiciones de celulas t y usos de las mismas.
|
|
WO2020214957A1
(en)
|
2019-04-19 |
2020-10-22 |
Tcrcure Biopharma Corp. |
Anti-pd-1 antibodies and uses thereof
|
|
US12479890B2
(en)
|
2019-04-26 |
2025-11-25 |
The University Of North Carolina At Chapel Hill |
Chimeric antigen receptor constructs and their use in CAR-T cells
|
|
US11667712B2
(en)
*
|
2019-05-08 |
2023-06-06 |
Janssen Biotech, Inc. |
Materials and methods for modulating t cell mediated immunity
|
|
US20230149457A1
(en)
*
|
2019-07-17 |
2023-05-18 |
Case Western Reserve University |
Long lived t cells for treating hiv infection
|
|
WO2021016652A1
(en)
*
|
2019-07-29 |
2021-02-04 |
The University Of Melbourne |
METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
|
|
JP2022545196A
(ja)
*
|
2019-08-16 |
2022-10-26 |
ガンマデルタ セラピューティクス リミテッド |
抗ｔｃｒデルタ可変１抗体の治療的使用
|
|
EP4045635A4
(en)
*
|
2019-10-17 |
2023-10-25 |
The University of Hong Kong |
METHODS FOR PREPARING EXOSOMES DERIVED FROM T-V LYMPHOCYTES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH EPSTEIN-BARR VIRUS
|
|
EP4051710B1
(en)
|
2019-10-31 |
2025-11-26 |
Incyte Corporation |
Anti-tumor combination therapy comprising anti-cd19 antibody and gamma delta t-cells
|
|
WO2021113558A2
(en)
*
|
2019-12-03 |
2021-06-10 |
Adicet Bio, Inc. |
METHODS FOR EXPANDING γδ T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF
|
|
CN115427436A
(zh)
|
2020-01-24 |
2022-12-02 |
里珍纳龙药品有限公司 |
黑素瘤优先表达抗原（prame）t细胞受体及其使用方法
|
|
JP2023516347A
(ja)
*
|
2020-03-03 |
2023-04-19 |
ヤンセン バイオテツク，インコーポレーテツド |
＃δＴ細胞及びその使用
|
|
IL297751A
(en)
|
2020-04-28 |
2022-12-01 |
Lyell Immunopharma Inc |
Methods for culturing cells
|
|
CN115996733A
(zh)
*
|
2020-06-22 |
2023-04-21 |
南京传奇生物科技有限公司 |
用于免疫疗法的基因工程化γδT细胞
|
|
CN116323667A
(zh)
|
2020-07-08 |
2023-06-23 |
拉法医疗股份有限公司 |
结合PSMA和γ-δT细胞受体的抗体
|
|
CN116333997A
(zh)
*
|
2020-07-14 |
2023-06-27 |
广州泛恩生物科技有限公司 |
基于cd109阳性t细胞的用于杀伤肿瘤的tcr-t细胞及其制备方法和应用
|
|
JP2024507735A
(ja)
*
|
2021-02-08 |
2024-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
ブチロフィリンサブファミリー３メンバーａ１（ｂｔｎ３ａ１、ｃｄ２７７）の制御
|
|
GB202105113D0
(en)
*
|
2021-04-09 |
2021-05-26 |
Gammadelta Therapeutics Ltd |
Novel method
|
|
JP2024539088A
(ja)
*
|
2021-10-20 |
2024-10-28 |
ユニバーシティ オブ ピッツバーグ －オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
腫瘍浸潤ガンマ－デルタｔ細胞を拡大するための方法及び材料
|
|
WO2023092119A2
(en)
|
2021-11-22 |
2023-05-25 |
Ludwig Institute For Cancer Research Ltd |
Methods for predicting responsiveness to a cancer therapy
|
|
JP2024542815A
(ja)
*
|
2021-12-05 |
2024-11-15 |
アディセット セラピューティクス， インク． |
Ｂ細胞悪性腫瘍の治療
|
|
KR20230105166A
(ko)
|
2022-01-03 |
2023-07-11 |
주식회사 이뮤노맥스 |
감마-델타 t 세포의 증식 배양 방법
|
|
CN114149978B
(zh)
*
|
2022-02-09 |
2022-04-26 |
深圳博雅感知药业有限公司 |
制备car-t细胞的方法
|
|
CA3250985A1
(en)
|
2022-02-16 |
2023-08-24 |
Priothera Sas |
CAR CELL TREATMENT METHODS IN COMBINATION WITH S1P RECEIVER MODULATORS
|
|
GB202204926D0
(en)
|
2022-04-04 |
2022-05-18 |
Gammadelta Therapeutics Ltd |
Method for expanding gammadelta T cells
|
|
WO2023242434A1
(en)
*
|
2022-06-17 |
2023-12-21 |
Gadeta B.V. |
Modified immune cells
|
|
CN115624618A
(zh)
*
|
2022-09-16 |
2023-01-20 |
深圳善乐生物科技有限公司 |
一种HPV多肽抗原负载γδT细胞在HPV阳性宫颈癌免疫治疗中的应用
|
|
IL320128A
(en)
|
2022-10-31 |
2025-06-01 |
Regeneron Pharma |
Methods for treating cancer using a combination of adoptive cell therapy and a targeted immunocytokine
|
|
AU2024253044A1
(en)
|
2023-04-07 |
2025-10-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating cancer with a lymphotoxin beta receptor agonist
|
|
AU2024275280A1
(en)
|
2023-05-25 |
2026-01-22 |
Regeneron Pharmaceuticals, Inc. |
T cell receptors that bind presented hpv16-, mart1-, cmv-, ebv-, or influenza- peptides
|
|
US12221483B1
(en)
*
|
2024-01-30 |
2025-02-11 |
China Medical University Hospital |
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
|
|
WO2025165915A1
(en)
*
|
2024-01-31 |
2025-08-07 |
Adicet Therapeutics, Inc. |
Compositions and methods for enhancing engineered t cell therapies
|
|
WO2025223534A1
(en)
*
|
2024-04-26 |
2025-10-30 |
Nanjing Legend Biotech Co., Ltd. |
Methods for expanding t cells
|
|
WO2025229538A1
(en)
*
|
2024-05-01 |
2025-11-06 |
Janssen Biotech, Inc. |
Materials, methods, and systems for cellular expansion of gamma delta t-cells
|
|
WO2026013158A1
(en)
*
|
2024-07-10 |
2026-01-15 |
Cytospire Therapeutics Limited |
Antibodies binding to constant domains of gamma delta t-cell receptors
|
|
WO2026013159A1
(en)
*
|
2024-07-10 |
2026-01-15 |
Cytospire Therapeutics Limited |
Antibodies binding to constant domains of gamma delta t-cell receptors
|